Pathstone Holdings’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $466K | Sell |
8,471
-1,478
| -15% | -$81.2K | ﹤0.01% | 1749 |
|
|
2025
Q1 | $703K | Buy |
9,949
+77
| +0.8% | +$5.44K | ﹤0.01% | 1548 |
|
|
2024
Q4 | $649K | Sell |
9,872
-39
| -0.4% | -$2.56K | ﹤0.01% | 1614 |
|
|
2024
Q3 | $697K | Hold |
9,911
| – | – | ﹤0.01% | 1550 |
|
|
2024
Q2 | $816K | Buy |
9,911
+742
| +8% | +$61.1K | ﹤0.01% | 1433 |
|
|
2024
Q1 | $801K | Buy |
9,169
+1,855
| +25% | +$162K | ﹤0.01% | 1420 |
|
|
2023
Q4 | $705K | Buy |
+7,314
| New | +$705K | ﹤0.01% | 1291 |
|